Foods and liver health

Molecular Aspects of Medicine

Volumn 29, Issue 1-2, 2008, Pages 144-150

  Morisco, Filomena ^a   Vitaglione, Paola ^a   Amoruso, Daniela ^a   Russo, Barbara ^a   Fogliano, Vincenzo ^a   Caporaso, Nicola ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Antioxidants; Functional foods; Human nutrition; Liver health; Polyunsaturated fatty acids

Indexed keywords

4 HYDROXYNONENAL; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; POLYUNSATURATED FATTY ACID; PROBIOTIC AGENT; SUPEROXIDE DISMUTASE;

ALCOHOLIC FATTY LIVER; CARDIOVASCULAR RISK; CHRONIC HEPATITIS; DRUG ABSORPTION; DRUG METABOLISM; FATTY LIVER; FOOD INTAKE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER FIBROSIS; LIVER INJURY; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; QUALITY OF LIFE; REVIEW;

ANTIOXIDANTS; FATTY ACIDS, UNSATURATED; FOOD; HUMANS; LIVER; LIVER DISEASES; OXIDATIVE STRESS;

EID: 39749098834     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2007.09.003     Document Type: Review

References (48)

1. Alwayn I.P., Andersson C., Zauscher B., Gura K., Nose V., and Puder M. Omega-3 fatty acids improve hepatic steatosis in a murine model: Potential implications for the marginal steatotic liver donor. Transplantation 79 (2005) 606-608
2. Araya J., Rodrigo R., Videla L.A., Thielemann L., Orellana M., Pettinelli P., and Poniachik J. Increase in long-chain polynsaturated fatty acids n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic steatohepatitis. Clin. Sci. 106 (2004) 635-643
3. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P.J., Poosala S., Becker K.G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Le Couteur D., Shaw R.J., Navas P., Puigserver P., Ingram D.K., de Cabo R., and Sinclair D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006) 337-342
4. Bedogni G., Miglioli L., Masutti F., Tiribelli C., Marchesini G., and Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42 (2005) 44-52
5. Bengmark S. Use of some pre-, pro- and synbiotics in critically ill patients. Best Pract. Res. Clin. Gastroenterol. 17 (2003) 833-848
6. Capanni M., Calella F., Biagini M.R., Genise S., Raimondi L., Bedogni G., Svegliati-Baroni G., Sofi F., Milani S., Abbate R., Surrenti C., and Casini A. Prolonged n - 3 polynsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment. Pharmacol. Ther. 23 (2006) 1143-1151
7. Cesaratto L., Vascotto C., Calligaris S., and Tell G. The importance of redox state in liver damage. Ann. Hepatol. 3 (2004) 86-92
8. Commission Directive 1999/21/EC. 25 March 1999 Dietary foods for special medical purposes Official Journal L 091, 07/04/1999 P. 0029 - 0036.
9. Fogliano V., and Vitaglione P. Functional foods: planning and development. Mol. Nutr. Food Res. 49 (2005) 256-262
10. Ghosh S., VanHeel D., and Playford R.J. Probiotics in inflammatory bowel disease: is it all gut ora modulation?. Gut. 53 (2004) 620-622
11. Gibney M.J., Vorster H.H., and Kok F.J. Introduction to Human Nutrition Edited on behalf of The Nutrition Society (2002), Blackwell Publishing
12. Godichaud S., Krisa S., Couronn'e B., Dubuisson L., Mérillon J.M., Desmoulière A., and Rosenbaum J. Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol. Hepatology 31 (2000) 922-931
13. Gronlund M.M., Arvilommi H., Kero P., Lehtonen O.P., and Isolauri E. Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months. Arch. Dis. Child. Fetal Neonatal Ed. 83 (2000) F186-F192
14. Hickman I.J., Clouston A.D., Macdonald G.A., Purdie D.M., Prins J.B., Ash S., Jonsson J.R., and Powell E.E. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut. 51 (2002) 89-94
15. Ip E., Farrel G., Hall P., Robertson G., and Leclerq I. Administration of the potent PPRAalfa agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology 39 (2004) 1286-1296
16. Kawada N., Seki S., Inoue M., and Kuroki T. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology 27 (1998) 1265-1274
17. Kikugawa K., Yasuhara Y., Ando K., Koyama K., Hiramoto K., and Suzuki M. Effect of supplementation of n - 3 polyunsaturated fatty acids on oxidative stress-induced DNA damage of rat hepatocytes. Biol. Pharm. Bull. 26 (2003) 1239-1244
18. Kochetova M.M., Eremina I.V., Kliuchnikova Zh.I., Solov'eva E.F., Butusova N.N., Torkhovskaia T.I., and Khalilov E.M. The antiatherogenic action of plant oils with added omega-3 polyunsaturated fatty acids. Biull. Eksp. Biol. Med. 116 (1993) 407-409
19. Lee Y.K., Lim C.Y., Teng W.L., Ouwehand A.C., Tuomola E.M., and Salminem S. Quantitative approach in the study of adhesion of lactic acid bacteria on intestinal cells and their competition with enterobacteria. Appl. Environ. Microbiol. 66 (2000) 3692-3697
20. Lee S., Gura K.M., and Puder M. Omega-3 fatty acids and liver disease. Hepatology 45 (2007) 841-845
21. Levy J.R., Clore J.N., and Stevens W. Dietary n - 3 polynsaturated fatty acids decrease hepatic triglycerides in Fisher 344 rats. Hepatology 38 (2003) 1529-1539
22. Li Z., Yang S., Lin H., Huang J., Watkins P.A., Moser A.B., Desimone C., Song X.Y., and Diehl A.M. Probiotics and antibodies to TNF inhibit inammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37 (2003) 343-350
23. Lin M.Y., and Chang F.J. Antioxidant effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356. Dig. Dis. Sci. 45 (2000) 1617-1622
24. Lirussi F., Mastropasqua E., Orlando S., and Orlando R. Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database Syst. Rev. 24 (2007) CD005165
25. Loguercio C., De Girolamo V., Federico A., Feng S.L., Crafa E., Cataldi V., Gialanella G., Moro R., and Del Vecchio Blanco C. Relationship of blood trace elements to liver damage, nutritional status, and oxidative stress in chronic nonalcoholic liver disease. Biol. Trace Elem. Res. 81 (2001) 245-254
26. Madsen K., Cornish A., Soper P., McKaigney C., Jijon H., Yachimec C., Doyle J., Jewell L., and De Simone C. Probiotics bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121 (2001) 580-591
27. Marotta F., Barreto R., Wu C.C., Naito Y., Gelosa F., Lorenzetti A., Yoshioka M., and Fesce E. Experimental acute alcohol pancreatitis-related liver damage and endotoxemia: synbiotics but not metronidazole have a protective effect. Chin. J. Dig. Dis. 6 (2005) 193-197
28. Mathurin P., Deng Q.G., Keshavarzian A., Choudhary S., Holmes E.W., and Tsukamoto H. Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology 32 (2000) 1008-1017
29. Milani S., Herbst H., Schuppan D., Surrenti C., Riecken E.O., and Stein H. Cellular localization of type I, III, and IV procollagen gene transcripts in normal and fibrotic human liver. Am. J. Pathol. 137 (1990) 59-70
30. Monvoisin A., Neaud V., De Ledinghen V., Dubuisson L., Balabaud C., Bioulac Sage P., and Desmouli'ere A. Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase. J. Hepatol. 30 (1999) 511-518
31. Morisco F., Vitaglione P., Carbone A., Stingo S., Scarpati S., Ascione A., Marmo R., Fogliano V., and Caporaso N. Tomato-based functional food as interferon adjuvant in HCV eradication therapy. J. Clin. Gastroenterol. 38 (2004) S118-S120
32. Myhrstad M.C., Carlsen H., Dahl L.I., Ebihara K., Glemmestad L., Haffner K., Moskaug J., and Blomhoff R. Bilberry extracts induce gene expression through the electrophile response element. Nutr. Cancer 54 (2006) 94-101
33. Neaud V., Faouzi S., Guirouilh J., Le Bail B., Balabaud C., Bioulac-Sage P., and Rosenbaum J. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: Evidence for a role of hepatocyte growth factor. Hepatology 26 (1997) 1458-1466
34. Neuschwander-Tetri B.A. Fatty liver and the metabolic syndrome. Curr. Opin. Gastroenterol. 23 (2007) 193-198
35. Parola M., and Robino G. Oxidative stress-related molecules and liver fibrosis. J. Hepatol. 35 (2001) 297-306
36. Pellegrini N., Riso P., and Porrini M. Tomato consumption does not affect the total antioxidant capacity of plasma. Nutrition 16 (2000) 268-271
37. Qureshi K., and Abrams G.A. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J. Gastroenterol. 13 (2007) 3540-3553
38. Resta-Lenert S., and Barrett K.E. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut. 52 (2003) 988-997
39. Rubino R., Sepe L., Dimitriadou A., and Gibon A. Livestock farming system. Product Quality Based on Local Resources Leading to Improved Sustainability (2005), Wageningen Academic Publishers EAAP publication No. 118
40. Schmöcker C., Weylandt K.H., Kahlke L., Wang J., Lobeck H., Tiegs G., Berg T., and Kang J.X. Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines. Hepatology 45 (2007) 864-869
41. Solga S.F., and Diehl A.M. Gut flora-based therapy in liver disease? The liver cares about the gut. Hepatology 39 (2004) 1197-1200
42. Solga S., Alkhuraishe A.R., Clark J.M., Torbenson M., Greenwald A., Diehl A.M., and Magnuson T. Dietary composition and nonalcoholic fatty liver disease. Dig. Dis. Sci. 49 (2004) 1578-1583
43. Tilg H., and Diehl A.M. Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med. 343 (2000) 1467-1476
44. Vitaglione P., Morisco F., Caporaso N., and Fogliano V. Dietary antioxidant compounds and liver health. Crit. Rev. Food Sci. Nutr. 44 (2004) 575-586
45. Vitaglione P., Sforza S., Galaverna G., Ghiaini C., Caporaso N., Fogliano V., Vescovi P., and Marchelli R. Bioavailability of trans-resveratrol from red wine in humans. Mol. Nutr. Food Res. 49 (2005) 495-504
46. Vitaglione P., Donnarumma G., Napolitano A., Galvano F., Gallo A., Scalfi L., and Fogliano V. Protocatechuic acid is the major human metabolite of cyanidin-glucosides. J. Nutr. 137 (2007) 2043-2048
47. Vitaglione P., Fogliano V., Stingo S., Scalfi L., Caporaso N., and Morisco F. Development of a tomato-based food for special medical purposes as therapy adjuvant for patients with HCV infection. Eur. J. Clin. Nutr. 61 (2007) 906-915
48. Zeuzem S. Gut-liver axis. Int. J. Colorectal Dis. 15 (2000) 59-82